V029-9875 Screening compound: N-cyclohexyl-2-(4-fluorophenyl)-N-{2-[3-(4-methoxyphenyl)-1,2,4-oxadiazol-5-yl]ethyl}acetamide

V029-9875 Screening compound: N-cyclohexyl-2-(4-fluorophenyl)-N-{2-[3-(4-methoxyphenyl)-1,2,4-oxadiazol-5-yl]ethyl}acetamide
V029-9875 Screening compound: N-cyclohexyl-2-(4-fluorophenyl)-N-{2-[3-(4-methoxyphenyl)-1,2,4-oxadiazol-5-yl]ethyl}acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V029-9875
N-cyclohexyl-2-(4-fluorophenyl)-N-{2-[3-(4-methoxyphenyl)-1,2,4-oxadiazol-5-yl]ethyl}acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V029-9875

Molecular Formula

C25H28FN3O3 (C25 H28 FN3 O3)

Compound Name

N-cyclohexyl-2-(4-fluorophenyl)-N-{2-[3-(4-methoxyphenyl)-1,2,4-oxadiazol-5-yl]ethyl}acetamide

IUPAC name

N-cyclohexyl-2-(4-fluorophenyl)-N-{2-[3-(4-methoxyphenyl)-124-oxadiazol-5-yl]ethyl}acetamide

SMILES

COc(cc1)ccc1-c1noc(CCN(C2CCCCC2)C(Cc(cc2)ccc2F)=O)n1

InChI

InChI=1S/C25H28FN3O3/c1-31-22-13-9-19(10-14-22)25-27-23(32-28-25)15-16-29(21-5-3-2-4-6-21)24(30)17-18-7-11-20(26)12-8-18/h7-14,21H,2-6,15-17H2,1H3

InChI Key

ZVCCLKUHQYZCSQ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD20489724

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

437.51

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

5.740

Distribution Coefficient, logD

5.740

Water Solubility, LogSw

-5.36

Polar Surface Area

53.760

Acid Dissociation Constant (pKa)

18.06

Base Dissociation Constant (pKb)

4.04

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

40.00

V029-9875 in Drug Discovery

Included in Screening Libraries

3CLpro Library (4801 compounds)

CORONAVIRUS Library (20774 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds

References: we are preparing a list of scientific research reports with V029-9875 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V029-9875?
Check Price and Availability of V029-9875, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V029-9875 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V029-9875
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V029-9875
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V029-9875 available by request